Viewing Study NCT02368704


Ignite Creation Date: 2025-12-24 @ 9:11 PM
Ignite Modification Date: 2026-02-25 @ 8:19 PM
Study NCT ID: NCT02368704
Status: UNKNOWN
Last Update Posted: 2016-04-18
First Post: 2015-02-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Role of Endoplasmic Reticulum Stress in the Pathophysiology of Type 2 Diabetes
Sponsor: Assistance Publique - Hôpitaux de Paris
Organization:

Study Overview

Official Title: Role of Endoplasmic Reticulum Stress in the Pathophysiology of Type 2 Diabetes
Status: UNKNOWN
Status Verified Date: 2016-04
Last Known Status: ACTIVE_NOT_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: GLUCOSTRESS
Brief Summary: The purpose of this study is to investigate whether Endoplasmic Reticulum (ER) stress pathway is activated in peripheral tissues (adipose tissue) in insulin resistant diabetic patients compared to healthy subjects normoglycemic matched for age and sex an to investigate whether ER stress pathway can be activated in response to insulin. Indeed, some preliminar on rates studies shows that ER stress pathway is activated by insulin in liver and adipose tissue showing that hyperinsulinemia might help trigger stress path ER.

For this, we propose a case control study of type 2 diabetic patients vs control subjects in which markers of ER stress will be evaluated from abdominal subcutaneous adipose tissue obtained before and after euglycemic hyperinsulinemic. We chose to consider adipose tissue subcutaneous rather than visceral adipose tissue for obvious reasons of lesser invasiveness.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: